Key result
Post-cardiac transplant patients average 1.5 respiratory infections over 48 months, with lethal fungal cases.
Why the study?
Lung infections are the most common cause of mortality and morbidity in heart transplant recipients, influenced by immunosuppressive treatment factors.
What is the prevalence and type of lung infections in cardiac transplant recipients receiving immunosuppressive therapy?
Observational (n=37)
No
What is the prevalence and type of lung infections in cardiac transplant recipients receiving immunosuppressive therapy?
Respiratory infections are highly prevalent in cardiac transplant recipients, with fungal and specific infections carrying a high risk of mortality.
Answers are grounded in this paper and cite their sources.
Data on pulmonary infections in heart transplant recipients remain preliminary; leaves open optimal prophylaxis strategies.
Lung infections represent the most common cause of mortality and morbidity in heart transplant recipients. The most important factors which determine the prevalence and type of infection in this category of patients are those related to type, regimen and length of immunosuppressive treatment. The objectives of this study involve the assessment of the prevalence of pulmonary infections and the impact of the antibacterial, antiviral prophylactic treatment on the onset of different lung infections, following heart transplantation. Over the course of 48 months, we monitored 37 consecutive patients with cardiac transplant. Immunosuppressive therapy (cyclosporine, tacrolimus and prednisone) was administered. Post-transplant pulmonary infections were monitored. The etiological diagnosis (bacterial, viral, fungal and parasitic) was determined through the following methods: bacteriology, serum serology, sputum samples, bronchial biopsy, chest X-ray or chest CT scan respectively. The mean age was 39 (range: 12 to 59 years). There were 28 male (75.7%) and 9 female (24.3%) patients. During the first 6 months following the transplant, 12 patients developed viral pneumonia, 6 bacterial pneumonia, 3 pulmonary aspergillosis, 2 pulmonary tuberculosis. During the study, a total of 58 cases of respiratory infections were recorded, with a rate of 1.5 episodes per patient. Different Gram positive and Gram negative bacterial infections, mainly community acquired, did not result in severe complications compared to fungal and specific infections which had a lethal outcome.
No takes yet. Share an insight, caveat, or question.
Ţilea et al. (2013) conducted an observational in Cardiac transplant recipients (n=37). Cardiac transplantation and immunosuppressive therapy was evaluated on Prevalence of respiratory infections. Over 48 months, 37 cardiac transplant recipients experienced 58 respiratory infections, with fungal and specific infections resulting in lethal outcomes.
Synapse has enriched 10 related papers. Consider them for comparative context: